Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis?:A Randomized Control Trial

Yates, Max, Hamilton, Louise E, Elender, Frances, Dean, Loretta, Doll, Helen, MacGregor, Alex J., Thomas, Joegi and Gaffney, Karl (2015) Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis?:A Randomized Control Trial. Journal of Rheumatology, 42 (7). pp. 1177-1185. ISSN 0315-162X

[img] PDF (Copyright-Transfer-April-2013)
Restricted to Repository staff only until 31 December 2099.

Download (32kB) | Request a copy
[img] Microsoft Word (FinalAnswersClean 10th Mar2015) - Submitted Version
Download (73kB)

Abstract

To investigate, in a pilot randomized controlled trial, whether etanercept (ETN) 25 mg once weekly is effective at maintaining a clinical response in patients with ankylosing spondylitis (AS) who have responded to the standard 50 mg dose.

Item Type: Article
Uncontrolled Keywords: ankylosing spondylitis,anti-tumor necrosis factor therapy,etanercept,randomized control trial
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Faculty of Medicine and Health Sciences > Allied Health Professions
Depositing User: Pure Connector
Date Deposited: 19 Aug 2015 15:16
Last Modified: 22 Jul 2020 00:20
URI: https://ueaeprints.uea.ac.uk/id/eprint/54126
DOI: 10.3899/jrheum.141335

Actions (login required)

View Item View Item